Opioid receptor-mediated effects of interleukin-2 on the [Ca2+]i transient and contraction in isolated ventricular myocytes of the rat

Pflugers Archiv European Journal of Physiology

Volumn 443, Issue 4, 2002, Pages 635-642

  Cao, Chun Mei ^a   Xia, Qiang ^a   Chen, Ying Ying ^a   Zhang, Xiong ^a   Shen, Yue Liang ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Contraction; G protein; Interleukin 2; Intracellular Ca2+; Opioid receptors; Phospholipase C; Ventricular myocytes

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; BINALTORPHIMINE; GENISTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN; INTERLEUKIN 2; KAPPA OPIATE RECEPTOR; NALOXONE; NALTRINDOLE; OPIATE ANTAGONIST; PERTUSSIS TOXIN; PHOSPHOLIPASE C; PHOSPHOLIPASE C INHIBITOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CELL ISOLATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; HEART MUSCLE CELL; INOTROPISM; MALE; MUSCLE FIBER CONTRACTION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; SPECTROFLUOROMETRY;

3,4-DICHLORO-N-METHYL-N-(2-(1-PYRROLIDINYL)-CYCLOHEXYL)-BENZENEACETAMIDE, (TRANS)-ISOMER; ANALGESICS, NON-NARCOTIC; ANIMALS; CALCIUM; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; HEART VENTRICLES; INTERLEUKIN-2; MALE; MUSCLE FIBERS; MYOCARDIAL CONTRACTION; MYOCARDIUM; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 0036185333     PISSN: 00316768     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00424-001-0743-3     Document Type: Article

References (46)

1. Genistein, a specific inhibitor of tyrosine-specific protein kinases
2. Cytokine-inducible nitric oxide synthase (iNOS) expression in cardiac myocytes. Characterization and regulation of iNOS expression and detection of iNOS activity in single cardiac myocytes in vitro
3. Cytokines and natural regulators of cytokines
4. Phospholipase C inhibitors attenuate arrhythmias induced by κ-receptor stimulation in the isolated rat heart
5. Serum interleukin-2 (IL-2), soluble IL-2 receptors and tumor necrosis factor-alpha levels are significantly increased in acute myeloid leukemia patients
6. Behavioural and ECoG spectrum changes induced by intracerebral infusion of interferons and interleukin 2 in rats are antagonized by naloxone
7. Activation of the interleukin 2 receptor: A possible role for tyrosine phosphatases
8. Isolation of calcium tolerant myocytes from adult rat hearts: Review of the literature and description of a method
9. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
10. Mu-, delta-, kappa-opioid receptors and their subtypes. A critical review with emphasis on radioligand binding experiments
11. Impaired left ventricular filling rate induced by treatment with recombinant interleukin 2 for advanced cancer
12. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness
13. Interleukin-1 beta induces long-term increase of axonally transported opiate receptors and substance P
14. Possible mechanism of the interleukin-2 in central nervous system
15. Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer
16. Interaction between endogenous opioids and IL-2 on PHA-stimulated human lymphocytes
17. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death
18. Cytokines in the pathogenesis and treatment of infectious diseases
19. Comparison of subcutaneous and intravenous interleukin-2 in asymptomatic HIV-1 infection: A randomised controlled trial
20. Impact of the number of treatment courses on the clinical response of patients who receive high-dose bolus interleukin-2
21. Increased circulating cytokines in patients with myocarditis and cardiomyopathy
22. Plasma levels of interleukin 2, 6, 10 and phenotypic characterization of circulating T lymphocytes in ischemic heart disease
23. The IL-2 receptor complex: Its structure, function, and target genes
24. Tonic regulation of excitation-contraction coupling by basal protein kinase C activity in isolated cardiac myocytes
25. Role of nitric oxide and peroxynitrite in the cytokine-induced sustained myocardial dysfunction in dogs in vivo
26. "Cross talk" between opioid peptide and adrenergic receptor signaling in isolated rat heart
27. Opiate receptors
28. 2+ accumulation in cardiac sarcoplasmic reticulum
29. Expression of cytokine-induced neutrophil chemoattractant in rat cardiac myocytes
30. 2+]i in myocytes
31. Effects of interleukin 2 on cardiac function in the isolated rat heart
32. Effects of IL-2 on the myocardium. Participation of the sympathetic system
33. Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy
34. 3H] U69593 binding sites in the rat heart by receptor binding assays
35. Negative inotropic effects of recombinant interleukin 2 in patients without left ventricular dysfunction
36. Kappa-opioid peptide receptor stimulation increases cytosolic pH and myofilament responsiveness to Ca2+ in cardiac myocytes
37. Kappa and delta opioid receptor stimulation affects cardiac myocyte function and Ca2+ release from an intracellular pool in myocytes and neurons
38. Nitric oxide mediated the inhibitory effects of interleukin-2 on the isolated ventricular papillary muscle and cultured neonatal rat cardiomyocyte
39. Effects of interleukin-2 on the isolated rat heart and the mechanism
40. Effects of cytokines on the contractility of cultured cardiac myocytes
41. Tissue distribution of opioid receptor gene expression in the rat
42. Signal transduction in the cardiac κ-receptor
43. Cardioprotection of preconditioning by metabolic inhibition in the rat ventricular myocyte. Involvement of kappa-opioid receptor
44. Effects of chronic U50,488H treatment on binding and mechanical responses of the rat heart
45. Endothelin-1 inhibits L-type Ca currents enhanced by isoproterenol in guinea pig ventricular myocytes
46. Hypothalamic neuronal responses to interleukin-6 in tissue slices: Effects of indomethacin and naloxone